Furthermore, STING was described to induce tolerogenic responses including expression of indoleamine-2,3-dioxygenase (IDO) in DCs fostering IL-10 production, myeloid suppressor cell recruitment and tumor progression of low-antigenic tumors [217,218]. The gene discussed is STING1; the disease is neoplasm.